Assessment of Oral Bioavailability of Vitamin D 3 and Its Metabolite, 25-hydroxy (OH) Vitamin D 3 in Male Sprague Dawley Rats Following a Single Oral Dose of Biofield Energy Treated Vitamin D 3

The present study was performed to determine the effects of The Trivedi Effect ® -Energy of Consciousness Healing Treatment on vitamin D 3 and rats through the pharmacokinetic parameters measurement of both plasma level of vitamin D 3 and 25-hydroxy (OH)-vitamin D 3 after the oral administration of vitamin D 3 in rats. The test item, vitamin D 3 was divided into two parts. One part was denoted as the control (without Biofield Energy Healing Treatment), while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment by renowned Biofield Energy Healer, Mahendra Kumar Trivedi. Additionally, one group of animals also received Consciousness Energy Healing Treatment per se by the Healer under similar conditions. Vitamin D 3 oral formulations were administrated by oral gavage at a dose of 500 μg per kg in groups viz. G1 (untreated Vitamin D 3 ), G2 (Biofield Energy Treated Vitamin D 3 ) and G3 (Biofield Energy Treated animals received untreated Vitamin D 3 ) group. The results showed that the relative oral exposure (AUC 0 –t) of vitamin D 3 was significantly increased by 155.62% and 111.73% in G2 and G3 groups, respectively as compared to the control group. Biofield Energy Treatment also significantly improved the plasma peak concentration (C max ) of vitamin D 3 by 223.84% and 187.5% in G2 and G3 groups, respectively as compared to the control group. This study results also showed that the relative oral exposure (AUC 0 –t) of 25-hydroxy (OH)-vitamin D 3 (metabolite) was significantly increased by 161.28% and 113.96% in G2 and G3 groups, respectively as compared to the control group (G1). Biofield Energy Treatment also significantly improved the plasma peak concentration (C max ) of 25-hydroxy (OH)-vitamin D 3 by 174.25% and 111.77% in G2 and G3 groups, respectively as compared to the control group. After oral administration, plasma concentrations of active metabolite, 25-hydroxy (OH)-vitamin D 3 in all three groups were declined slowly. The mean residence time (MRT last ) and elimination rate constant (K el ) for this metabolite were unaltered in all three groups. These data suggest that Biofield Energy Treated vitamin D 3 might be influenced in vivo biological activity of vitamin D 3 due to increased plasma exposure (AUC) of both vitamin D 3 and metabolite level, 25-hydroxy (OH)-vitamin D 3 in rats. There was significant improvement (>100%) of relative oral bioavailability of both vitamin D 3 and 25-hydroxy (OH)-vitamin D 3 that might be due to the alteration of physicochemical properties and thermal properties of vitamin D 3 by the Biofield Energy Treatment. Biofield Energy Healing Treatment could be an innovative strategy that opens new avenues to overcome poorly absorbed pharmaceuticals/nutraceuticals/herbal extracts and can also improve the therapeutic performance of orally active molecules.